Definitive Healthcare Corp (NASDAQ:DH) price on Friday, May 02, rose 3.27% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.84.
A look at the stock’s price movement, the close in the last trading session was $2.75, moving within a range at $2.785 and $2.88. The beta value (5-Year monthly) was 1.487. Turning to its 52-week performance, $7.47 and $2.15 were the 52-week high and 52-week low respectively. Overall, DH moved 1.79% over the past month.
Definitive Healthcare Corp’s market cap currently stands at around $432.50 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Analysts have a consensus estimate of 56.2M for the company’s revenue for the quarter, with a low and high estimate of 55M and 57.3M respectively. The average forecast suggests down to a -11.47% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 234.24M, representing a -7.12% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DH is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 4 analyst(s) rate the stock as a Hold, 5 recommend DH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
DH’s current price about 9.13% and -3.34% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.11, while 7-day volatility ratio is 4.08% and 5.80% in the 30-day chart. Further, Definitive Healthcare Corp (DH) has a beta value of 1.48, and an average true range (ATR) of 0.16. Analysts have given the company’s stock an average 52-week price target of $7, forecast between a low of $4 and high of $30. Looking at the price targets, the low is -40.85% off current price level while to achieve the yearly target high, price needs to move -956.34%. Nonetheless, investors will most likely welcome a -146.48% jump to $7 which is the analysts’ median price.
If we refocus on Definitive Healthcare Corp (NASDAQ:DH), historical trading data shows that trading volumes averaged 0.47 over the past 10 days and 1.07 million over the past 3 months. The company’s latest data on shares outstanding shows there are 113.95 million shares.
The 63.81% of Definitive Healthcare Corp’s shares are in the hands of company insiders while institutional holders own 37.74% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.5 million on 2025-04-15, giving us a short ratio of 2.68. The data shows that as of 2025-04-15 short interest in Definitive Healthcare Corp (DH) stood at 794.0 of shares outstanding, with shares short rising to 3.01 million registered in 2025-03-14. Current price change has pushed the stock -30.90% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DH stock continues to rise going into the next quarter.
